Our next webinar will be: 18 October 2022 in Glasgow. In person and live stream

Find out more
Join Us

Health Care Professionals (HCP)

This section is designed for Health Care Professionals and covers the latest information available for the treatment and management of SLL and CLL. We aim to keep this area up to date with developments in CLL research.

Latest CLL treatment guidelines

Earlier this year, the British Society of Haematology published new guidelines for the treatment of SLL/CLL. The full guidelines are available for review here.

Videos from the Joint UK CLL Forum and CLL Support two day seminar

Some of the comments from participants:

“Really superb speakers, great to feel the combination of evidence nuanced with their own personal practice.”

“All really good talks, Helen Marr in particular was excellent.”

“More than brilliant!”

” I thought it was particularly good, engaging and well chaired”

“Excellent presentations correlating research to clinical practice and recommendations.”

The key talks from this very informative seminar can be viewed here:

Day 1

Chaired by Prof George Follows, Consultant Haematologist, Visiting Professor of Haematology, Anglia Ruskin Medical School, Associate Lecturer, University of Cambridge.

Dr Rosalynd Johnston, Consultant haematologist, University Hospitals Sussex, Royal Sussex County Hospital.

CLL – Natural History; presentation; W & W; Complications related to CLL not Therapy

Dr Ben Kennedy, Consultant Haematologist and Honorary Associate Professor, Department of Haematology, Leicester Royal Infirmary.

CLL – Laboratory Work-Up and Prognostic Biology

Dr Piers Patten, Clinical Senior Lecturer and Honorary Consultant Haematologist, King’s College London. 

CLL First Line Therapy – Choices and Considerations

Day 2

Chaired by Dr R Walewska, Consultant Haematologist, University Hospitals, Dorset

Dr Helen Marr, Consultant Haematologist, Northern Centre for Cancer Care, Freeman Hospital, Newcastle.

CLL Relapsed Therapy – Choices and considerations

Professor Alan Bloor, Consultant Haematologist and MAHSC Honorary Clinical Chair, University of Manchester, Director of Cell Transplantation, The Christie Foundation Trust

Managing Complications of Standard CLL Treatments

Dr Niamh Appleby, Senior Clinical Researcher in Haematology, Molecular Haematology, John Radcliffe Hospital, Oxford.

CLL and Genomica: A New Standard?